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The effects of pentoxifylline on cochlear blood flow (CoBF) were investigated in anesthetized guinea pigs by laser Doppler 
flowmetry and intravital microscopy red blood cell velocity measurement. Intra-arterial infusion of pentoxifylline (3, 4, and 5 
mg/kg/min) produced dose-dependent reductions in blood pressure, accompanied by significant elevations in CoBF that were not 
dose-dependent. These results are in general agreement with previous findings from our laboratory utilizing normotensive and 
spontaneously hypertensive rats, however, in contrast with rats, guinea pigs revealed an initial decrease in CoBF followed by an 
increase. Also, pentoxifylline produced relatively smaller elevations in CoBF in guinea pigs as compared with those previously 
reported in rats. Taken together these results support the hypothesis that pentoxifylline increases vascular perfusion by decreasing 
blood viscosity and increasing the plasticity of red blood cells. 
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Introduction 
Decreases in cochlear blood flow (CoBF) re- 
duce oxygen and nutrient availability and removal 
of waste products from the inner ear, and have 
been suggested to contribute to functional pa- 
thologies of the inner ear (Axelsson et al., 1983; 
Dengerink and Wright, 1988; Hawkins, 1971). 
These otopathologies include noise-induced hear- 
ing loss and Meniere’s disease (Borg, 1982; Dulan 
et al., 1987). Since the cochlear vasculature repre- 
sents the principal route by which medical treat- 
ments can be delivered to the cochlea, increased 
CoBF may facilitate treatment of these otopathol- 
ogies (Dengerink and Wright, 1988). However, 
there are problems associated with increasing 
CoBF via: 1 vaso-constrictive agents such as 
angiotensin II (Wright et al., 1985) and vasopres- 
sin (Osborn et al., 1987) and blood volume expan- 
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sion agents such as glycerol (Larson et al., 1982a), 
dextran (Hultcrantz and Nuttall, 1987) and man- 
nitol (Larson et al., 1982b; Quirk et al., in press) 
given the concomitant increases in blood pressure; 
2) vasodilation using compounds such as vinca- 
mine (Coleman, unpublished observations) and 
carbogen (Goodwin et al., 1984; Melnick, 1984) 
which can promote a hypotensive response; and 3) 
osmotic agents such as dextran which may pro- 
duce rebound effects and kidney failure 
(Hultcrantz and Nuttall, 1987). There is the fur- 
ther problem that increases in CoBF can prompt 
local autoregulatory responses that may preclude 
increased blood flow (Lawrence et al., 1977; Miller 
and Dengerink, 1988; Quirk et al., 1988a, 1989). 
Our laboratory has been investigating various 
strategies to elevate CoBF while attempting to 
avoid, or diminish the above problems. It has been 
previously noted that increased blood viscosity 
and red blood cell (RBC) rigidity are closely re- 
lated to sensorineural hearing impairment (Brown- 
ing et al., 1986). We reasoned that if an agent 
could be found that decreased blood viscosity 
while having minimal effects on vasodilation, 
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blood osmolarity and pressure, its use for increas- 
ing CoBF may be superior to the presently availa- 
ble compounds. Pentoxifylline appears to be such 
a compound. This rheologic agent increases CoBF 
without elevating blood pressure, presumably by 
altering RBC membrane flexibility, thus promo- 
ting erythrocyte penetration into microcapillaries 
less than one-half their diameter (Antignani et al., 
1987; Ehrly, 1976; Manrique and Manrique, 1987). 
This improved circulation has been used to inhibit 
ischemic attacks and increase blood flow in pa- 
tients suffering from peripheral artery disease 
(Smith et al., 1986). 
A recent report from our laboratory utilizing 
rats (Quirk et al., 1988b) indicated that pentoxifyl- 
line decreased blood pressure in a dose-related 
fashion while facilitating CoBF. However, the 
guinea pig’s low baselevel blood pressure prompts 
the question as to whether pentoxifylline will be as 
effective in this species. We have previously re- 
ported that larger doses of angiotensin II were 
required to produce equivalent elevations in CoBF 
in the guinea pig as compared with the laboratory 
rat, while CoBF was more closely correlated with 
blood pressure in the guinea pig than the rat 
(Flynn et al., 1989). A second question concerns 
the validity of CoBF measurements using the laser 
Doppler flowmeter technique (Nuttall, 1988). 
Therefore, in the present investigation we com- 
pared the influence of pentoxifylline upon CoBF 
in the guinea pig utilizing the laser Doppler 
flowmetry and intravital microscopy techniques. 
Materials and Methods 
Animals and maintenance 
Male adult guinea pigs (Hartley strain) 120 to 
150 days of age, weighing from 400-600 g, were 
derived from stock obtained from Simonsen 
Laboratories (Gilroy, CA) and were housed in an 
AAALAC approved vivarium on a 12:12 h 
light : dark cycle initiated at 0700 h, with food and 
water available ad libitum. All animals in this 
study were utilized in strict accordance with NIH 
guidelines for animal research. 
Surgical and treatment protocol 
Twenty-four animals were randomly assigned 
to 1 of 3 groups (8 animals each), and anesthetized 
with Ketamine Hydrocholide (100 mg/kg, 
Bristol-Myers, Inc.) and Rompun (2 mg/kg, Haver 
Inc.). Each animal was prepared with a flow- 
through catheter of the right carotid artery (PE 60, 
Clay Adams) designed to allow infusion and con- 
tinuous recording of blood pressure. Details of 
this surgical procedure have been described 
elsewhere (Quirk et al., 1989). The left bulla was 
exposed and opened for access to the cochlea 
using a ventral approach. The needle probe (0.9 
mm o.d.) of the laser Doppler (Advanced Opto- 
kinetics Corporation, Model 2100) was placed on 
the basal turn of the cochlea via a micromanipula- 
tor as described by Goodwin et al. (1984). Blood 
pressure was monitored using a Statham trans- 
ducer (Model P23AC) and a Grass Instruments 
polygraph (Model-SD). Baselevel CoBF and blood 
pressure were monitored for at least 10 min or 
until stable. Once baselevel measures of CoBF and 
systemic blood pressure were achieved, an intra- 
arterial infusion of 0.15 M NaCl (50 pl/min) was 
initiated, followed by one dose of pentoxifylline 
(Sigma, P-1784: 3, 4, or 5 mg/kg/min in a volume 
of 50 ul/min of 0.15 M NaCI, Travenol 2F7124) 
titrated to a pH of 7.0&7.2. Thus, the animals of 
each group received a control infusion (0.15 M 
NaCl) and one of the doses of pentoxifylline with 
10 min between the control infusion and the 
pentoxifylline dose or until baselevel measures 
were regained. The infusions were counter-bal- 
anced with 4 guinea pigs of each group receiving 
pentoxifylline first and 4 guinea pigs receiving 
saline first. Blood pressure and CoBF were re- 
corded continuously throughout the baselevel 
period and subsequent 10 min infusion periods. 
For statistical purposes only 8 treatments with 
0.15 M NaCl were randomly selected from the 24 
total runs, and the systemic blood pressure and 
CoBF changes induced by this control treatment 
were compared against the effects of the three 
doses of pentoxifylline. 
Three additional guinea pigs were anesthetized 
as described above and were prepared for mea- 
surement of RBC velocity using the intravital mi- 
croscopy technique as developed by Nuttall 
(1987a). Again the bulla was exposed for access to 
the cochlea. A rectangular portion of bone (ap- 
proximately 0.2 x 0.3 mm) was scored by knife 
blade and removed to expose the stria vascularis 
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vessels in the second turn of the cochlea. These 
capillaries were monitored by a fluorescence video 
monitor with a magnification of approximately 
1000 x . 
To provide fluorescence of the plasma and 
thereby the exposed capillary network, 0.05 ml of 
FITC-dextran (MW = 150 kDa; 5% solution by 
weight in 0.15 M NaCl) was intra-arterially in- 
fused (Nuttall, 1987a,b). A tracking velocity corre- 
lator (RBC Velocity Tracking Correlator, Model 
102, Instrumentation for Physiology and Medi- 
cine, Inc., San Diego, CA) which utilizes photo- 
metric signals derived from detectors sensitive to 
light scintillation or modulation due to moving 
particles, was used for determining RBC velocity. 
These RBC velocities were measured before, dur- 
ing, and after the intra-arterial infusion of 0.15 M 
NaCl (50 pl/rnin for 10 min) and pentoxifylline 
(7.5 mg/kg/min for 10 min). 
Statistical analyses 
For those animals utilized in the laser Doppler 
flowmetry experiment, baselevel blood pressures 
prior to treatment were compared by a one-way 
analysis of variance (ANOVA). Maximum changes 
in blood pressure from baselevel were scored at 30 
s intervals throughout each 10 min infusion period 
for each animal. This blood pressure data set was 
submitted to a 4 (groups) x 2 (doses) ANOVA 
with repeated measures on the second factor. The 
CoBF measures were scored as a percent of 
baselevel, and because they did not meet the as- 
sumptions of the ANOVA they were submitted to 
Chi-square non-parametric analysis. Significant 
effects were further evaluated by Newman-Keuls 
post-hoc tests with the level of significance set at 
P < 0.01. 
The blood pressure and CoBF changes mea- 
sured prior to, and during, the infusion of 
pentoxifylline using the intravital microscopy 
technique were evaluated using t-tests for related 
measures. 
Results 
There were no significant differences in pre-in- 
fusion anesthetized baselevel blood pressure 
among the treatment groups utilized for de- 
termination of CoBF by laser Doppler flowmetry. 
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Fig. 1. Maximum changes in blood pressure (upper panel) and 
cochlear blood flow (lower panel) from baselevel induced by 10 
mm infusions of 0, 3,4, and 5 mg/kg/min doses of pentoxifyl- 
line. The mean (5 SEM) blood pressure baselevel before infu- 
sion was 52.3 (+1.3) mm Hg. The maximum decreases in 
blood pressure were 11.9 (+ 0.3) 12.9 (k 0.2) and 16.4 (k 0.2) 
mm Hg for the 3, 4, and 5 mg/kg doses, respectively. The 
maximum elevations in CoBF were 8.9 (*2.9), 11.6 (54.9) 
and 9.7 ( f 2.5)% for the 3.4, and 5 mg/kg doses, respectively. 
The overall mean ( f SEM) baselevel blood pres- 
sure across groups during the pre-infusion period 
was 52.3 (f1.3) mm Hg. Fig. 1 (top panel) pre- 
sents the maximum change in blood pressure in- 
duced by each dose of pentoxifylline. Although 
the 0.15 M NaCl infusion yielded minimal effects 
on blood pressure, significant decreases were ob- 
served following the infusion of the 3, 4, and 5 
mg/kg/min doses of pentoxifylline, and these de- 
creases followed a dose-response pattern: 11.9 
(+0.3), 12.9 (kO.1) and 16.4 (fO.2) mm Hg, 
respectively (F = 18.28, df = 3,28, P < 0.001). 
Post-hoc analyses indicated that each dose was 
significantly different from the next. These de- 
creases in blood pressure represented percent de- 
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Fig. 2. Mean changes in blood pressure (upper panel)- and 
cochlear blood flow (lower panel) during infusion of 0.15 M 
NaCl or the 4 mg/kg/min dose of pentoxifylline. The mean 
decrease in blood pressure during pentoxifylline infusion was 
12.9 mm Hg, while the maximum increase in CoBF above 
baselevel was 12.1%. The 4 mg/kg/min dose of pentoxifylline 
is representative of the 3 and 5 mg/kg/min doses. 
Fig. 1 (bottom panel) displays the maximum 
changes in CoBF for each dose of pentoxifylline. 
Chi-square analysis indicated that these elevations 
in CoBF were significantly different from basele- 
vel. Specifically, the doses 3, 4, and 5 mg/kg/min 
of pentoxifylline resulted in maximum elevations 
of 9.9 (f2.1) 12.1 (f4.7) and 9.7 (+2.5)%, re- 
spectively. Chi-square analysis for the 3, 4, and 5 
mg/kg doses yielded x2 = 14.75, 14.75, and 24.75 
respectively, P < 0.001. Fig. 2 presents the pat- 
terns of changes in blood pressure (top panel) and 1 
CoBF (bottom panel) for the 4 mg/kg dose of 
pentoxifylline which is representative of the other 
two doses. During the infusion there was a de- 
crease in blood pressure accompanied by an initial 
decrease in CoBF followed by a gradual continu- 
ous increase during the remainder of the infusion 
period. 
There was also a significant decrease in sys- 
temic blood pressure during pentoxifylline infu- 
sion (7.5 mg/kg/min) evidenced by those animals 
used for intravital microscopy analysis (r = 6.25, 
P < 0.001). This decrease was from a mean ( k SD) 
baselevel of 58 (+ 2.1) to 51 ( + 3.4) mm Hg. And 
there was a concomitant significant elevation in 
RBC velocity in the stria vascularis vessels in these 
animals, from 227.7 (_t 17.9) to 248.3 (_t22.7) 
pm/s (t = 2.49, P -c 0.05). During the 10 min 
post-infusion recovery period, systemic blood 
pressure recovered to baselevel while RBC velocity 
remained elevated at 255.5 ( _t 23.6) pm/s. 
Discussion 
The results of this investigation indicate that 
pentoxifylline increases cochlear blood flow in 
guinea pigs as previously reported for the labora- 
tory rat (Quirk et al., 1988b). These elevations in 
CoBF occurred despite significant decreases in 
systemic blood pressure that appear to be attribu- 
table to the rheological effects of pentoxifylline 
rather than any vasodilative effects (Ehrly, 1976; 
Smith, 1986). Although the present results from 
guinea pigs generally agree with the previous find- 
ings in rats (Quirk et al., 1988a) there were dif- 
ferences. In contrast with rats there was an initial 
decrease in CoBF during the infusion of the 3 and 
4 mg/kg/min doses followed by increases that 
did not follow a dose response pattern as seen in 
rats. Also in guinea pigs higher doses of pentoxi- 
fylline were required for effect and resulted in 
smaller reductions in absolute blood pressure than 
were observed in rats (Quirk et al., 1988a), al- 
though the average percent decrements in blood 
pressure from baselevel were greater in guinea pigs 
than rats. Specifically, the maximum percent de- 
crements in blood pressure from baselevel for rats 
were 10.2, 17.2, and 21.6%,. at the 1.5, 2, and 3 
mg/kg doses, respectively; while in guinea pigs 
these decrements were 22.8, 24.7, and 31.4% at 
doses of 3, 4. and 5 mg/kg, respectively. The most 
effective dose of pentoxifylline in those guinea 
pigs used for laser Doppler analysis was 4 mg/kg 
which promoted blood pressure decreases of ap- 
proximately 13 mm Hg, and CoBF increases of 
approximately 12% above baselevel. Although the 
5 mg/kg dose did not follow a dose-response 
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pattern it illustrates the effectiveness of pentoxi- 
fylline in elevating cochlear blood flow despite a 
blood pressure decrease of nearly 16.4 mm Hg 
(31.4% from baselevel). The increase in CoBF 
persisted beyond the period of infusion. 
The intravital microscopy results generally agree 
with those derived from laser Doppler flowmetry 
in that systemic blood pressure decreased during 
the infusion of pentoxifylline, while cochlear red 
blood cell velocity was elevated. It should be 
noted that a higher dose of pentoxifylline was 
employed in the animals used for intravital mi- 
croscopy measurements, and this dose yielded a 7 
mm Hg decrease in systemic blood pressure from 
baselevel, while the decreases noted in the animals 
used for laser Doppler analysis ranged from 11.9 
to 16.4 mm Hg. At present we have no ready 
explanation for this discrepancy. It is conceivable 
that this dampening of effect is due to differences 
in the amount of anesthetic given to these two 
groups of animals. Specifically, because intravital 
microscopy is more sensitive to animal movements 
than the laser Doppler flowmeter, the intravital 
microscopy animals may have been inadvertently 
maintained at a somewhat deeper anesthetic plane. 
This may have made the animals less responsive to 
the hypotensive effects of pentoxifylline (Flynn et 
al., 1988).Histological measures concerned with 
the impact of noise exposure on the cochlear 
vasculature generally suggest reduced blood flow 
with exposure to noise (Axelsson et al., 1981; 
Axelsson and Dengerink, 1987; Dengerink et al., 
1985). These findings have been corroborated with 
laser Doppler flowmetry (Thorn and Nuttall, 1987) 
and intravital microscopy (Quirk et al., 1990) stud- 
ies. Thus, if acoustic trauma results from diminu- 
tion of blood flow, then pentoxifylline may help to 
increment blood flow. With respect to basic re- 
search, compounds such as pentoxifylline may 
facilitate our understanding of cochlear blood flow 
dynamics and thus provide insight into the devel- 
opment of new more effective pharmacological 
treatments for otopathologies of vascular origin. 
Acknowledgements 
This research was supported by grants from the 
Deafness Research Foundation, NIH NS 11731, 
and funds provided by Washington State Univer- 
sity. Special thanks are due to Dr. A.L. Nuttall for 
his helpful comments on the preparation of this 
manuscript, and Mrs. Ruth Day for typing the 
manuscript in final form. 
References 
Antignani, P.L., Tododini, A.R., Saliceti, F., Pacino, G. and 
Bartolo, M. (1987) Results of the clinical, laboratory, and 
heamorheological investigations of the use of pentoxifylline 
in high doses. Pharmatherapeutica 5, 50-56. 
Axelsson, A. and Dengerink, H.A. (1987) Histological indica- 
tions of noise effects on the cochlear and red blood cells: A 
review. Hear. Res. 31, 183-192. 
Axelsson, A., Borg, E. and Hornstrand, C. (1983) Noise effects 
on cochlear vasculature in normotensive and spontaneously 
hypertensive rats. Acta Otolaryngol. 96, 215-225. 
Axelsson, A., Vertes, D. and Miller, J. (1981) immediate noise 
effects on cochlear vasculature in the guinea pig. Acta 
Otolaryngol. 91, 237-246. 
Borg, E. (1982) Noise induced heating loss in normotensive 
and spontaneously hypertensive rats. Hear. Res. 8, 117-130. 
Browning, G.G., Gatehouse, S. and Lowe, G.D.O. (1986) Blood 
viscosity as a factor in sensorineural hearing impairment. 
Lancet 1, 121-123. 
Dengerink, H.A. and Wright, J.W. (1988) Physiology of the 
ear. In: Jahn, A.F. and Santos-Sac&i, J.(Eds.), Circulation 
of the Inner Ear. Raven Press, New York. pp. 327-340. 
Dengerink, H., Miller, J., Axelsson. A., Vertes, D. and 
VanDalfsen, P. (1985) The recovery of vascular changes 
following brief noise exposure. Acta Otolaryngol. 100, 19- 
Dulan, D., Aran. J.M., and Schacht. J. (1987) Osmotically 
induced motility of the outer hair cells: implications in 
Meniere’s disease. Arch. Oto-~in~~ryngol. 244, 104- 
107. 
Ehrly, A. (1976) Improvement of the flow properties of blood: 
A new therapeutical approach in occlusive arterial disease, 
Angiology 24 (3). 188-196. 
Flynn, A.J.. Dengerink, H.A. and Wright, J.W. (1988) Blood 
pressure in resting, anesthetized and noise-exposed guinea 
pigs. Hear. Res. 34, 201-206. 
Flynn, A.J.. Quirk. W.S., Dengerink, H.A. and Wright, J.W. 
(1989) The effects of intracerebroventricularly administered 
angiotensin II on blood pressure and cochlear blood flow in 
rats and guinea pigs. Hear. Res. 41, 249-254. 
Goodwin, P.W.. Miller, J.M., Dengerink, H.A., Wright, J.W. 
and Axelsson, A. (1984) The laser Doppler: A non-invasive 
measure of cochlear blood flow. Acta-Oto-Laryngol, 
(Stockholm) 98, 403-412. 
Hawkins, J. (1971) The role of vasoconstriction on noise in- 
duced hearing loss. Ann. Otolaryngol. 80. 903-913. 
Hultcrantz, E. and Nuttall, A.L. (1987) Effect of hemodilation 
on cochlear blood flow measured by laser Doppler flowme- 
try. Am. J. Otolaryngol. 8, 10-16. 
Larson, H.C., Angelborg, C. and Hultcrantz, E. (1982a) The 
effects of urea and mannitol on cochlear blood flow. Acta 
Otolaryngol. 94. 249-252. 
174 
Larson, H.C.. Angelborg, C., and Huitcrantz, E. (1982b) The 
effect of glycerol on blood flow. Oto-Rhino-Laryngol. 44, 
101-107. 
Lawrence. M., Nuttall, A.L. and Burgio. P.A. (1977) Oxygen 
reserve and autoregulation in the cochlea. Acta Otolaryn- 
gol. 83, 146-152. 
Manrique, R.V. and M~rique, V. (1987) Enhancement of the 
antia~regatory effect of prostacyclin by pentoxifylline. 
Angiology 38 (2 Pt 1), 101-108. 
Melnick, W. (1984) Medicinal therapy for hearing loss result- 
ing from noise exposure. Am. J. Otolaryngol. 5, 425-431. 
Miller, J.M. and Dengerink. H.A. (1988) Control of inner ear 
blood flow. Abstr. Assoc. Res. Otolaryngol. Clearwater 
Beach, Florida. 
Nuttall, A.L. (1987a) Techniques for the observation and mea- 
surement of red blood cell velocity in vessels of the guinea 
pig cochlea. Hear. Res. 27. 111-119. 
Nuttall, A.L. (1987b) Velocity of red blood cell flow in 
capillaries of the guinea pig cochlea. Hear. Res. 27.121-128. 
Nuttall, A.L. (1988) Methodological approaches for measure- 
ment of cochlear blood flow. Paper Assoc. Res. Otolaryn- 
801. Clearwater Beach, Florida. 
Osborn, J.W., Skelton, M.M. and Cowley, A.W. (1987) Hemo- 
dynamic effects of vasopressin compared with angiotensin 
II in conscious rats. Am. J. Physiol. 252, 628-637. 
Quirk. W.S., Nuttall, A.L. and Miller, J.M. (1990) Noise-in- 
duced changes in red blood cell velocity and vessel diame- 
ter in the lateral wall of the rat cochlea. Abstr. Assoc. Res. 
Otolaryngol. Clearwater Beach, Florida. 
Quirk, W.S., Dengerink, H.A., Coleman. J.K. and Wright, J.W. 
(1989) Cochlear blood flow autoregulation in Wistar-Kyoto 
rats. Hear. Res. 41, 53-60. 
Quirk, W.S., Bademian. M.J., Wright, J.W. and Dengerink, 
H.A. Effects of mannitol and dextran on cochlear blood 
flow in normotensive and spontaneously hypertensive rats. 
Acta Otolaryngol. (in press). 
Quirk. W.S.. Wright, J.W.. Dengerink, H.A. and Miller, J.M. 
(1988a) Angiotensin 11 Induced changes in cochlear blood 
flow and blood pressure in normotensive and sponta- 
neously hypertensive rats. Hear. Res. 32, 1299136. 
Quirk, W.S., Dengerink, H.A., Bademian, M.J.. Hall, K.W., 
and Wright. J.W. (1988b) The effects of pentoxifylline in 
normotensive and spontaneously hypertensive rats. Hear. 
Res. 36. 175-180. 
Smith. R.V., Waller, ES.. Dolvisio, J.T., Bauza, M.T.. Puris. 
K.. Ho. I. and Lassman, H.B. (1986) Pharmacokinetics of 
orally administered pentoxifylline in humans. J. Pharm. Sci. 
7.5. 47-52. 
Thorn, P.R. and Nuttall, A.L. (1987) Laser Doppler measure- 
ments of cochlear blood flow during loud sound exposure 
in the guinea pig. Hear. Res. 27. l-10. 
Wright. J.W., Morseth. S.L.. Abhold, R.H. and Harding, J.W. 
(1985) Pressor action and dips~genicity induced by angio- 
tensin II and III in rats. Am. J. Physiol. 249, R514-R521. 
